The healthcare industry stands apart in its complexity and stakes—where every decision, every action can be a matter of life ...

US FDA clears HELP Therapeutics’ IND application for universal iPSC-derived HiCM-188 cell therapy to treat end-stage heart failure: Nanjing, China Wednesday, October 23, 2024, 1 ...

Nucleus RadioPharma expands radiopharmaceutical research, development and manufacturing capacity: Rochester, Minnesota Wednesday, October 23, 2024, 13:00 Hrs [IST] Nucleus RadioPh ...

Syngene International in its second quarter has reported revenue from operations increased sequentially by 13% but down 2% year-on-year to Rs. 891 crore compared to the corresponding quarter where it ...

OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME: Our Bureau, Bengaluru Wednesday, October 23, 2024, 16:40 Hrs [IST] OC Academy has in ...

BioVersys joins EU-funded RespiriNTM Programme to accelerate development of its broad-spectrum drug candidates against NTM pulmonary diseases: Basel, Switzerland Wednesday, Octobe ...

Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter: Düsseldorf, Tokyo Wednesday, October 23, 2024, 16:00 Hrs [IST] Asahi Kasei Medical has launched the ...

Oblique Therapeutics enters research collaboration pact with Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target: Stockholm, Sweden Wednesday, ...

EMA committee recommends approval of LINDIS Biotech’s Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas: Munich, Germany Wednesday, October 23, 2024 ...

Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...

EMA committee recommends extended authorization for BeiGene’s Tevimbra to treat gastric or gastroesophageal junction cancer & ESCC: San Mateo, California Wednesday, October 23, ...

Nuclidium announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging ...